In STEP 3, which reported the highest rates of GI AEs, 82.8% of patients treated with semaglutide 2.4 mg reported GI AEs vs 63.2% in the placebo arm
This participation rate was to be calculated as the enrollment in Part D plans applying to participate in the model divided by the total enrollment in all Part D plans, excluding special needs plans and employer plans, even though they are eligible to participate in the model, but including Defined Standard benefit plans, even though they are ineligible to participate
You should be ready to discuss: Any personal or family history of medullary thyroid carcinoma (MTC)
Important: If you are pregnant, planning pregnancy, or breastfeeding, consult your obstetrician or healthcare provider before taking glutathione or any dietary supplement
Disposal : Dispose of any used or expired pens properly, following local guidelines for medical waste